PUBCHEM ID | 8452 |
Molecular Weight (g/mol) | 84.119 |
Molecular Formula | C5H8O |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 1 |
IUPAC Name | |
Canonical SMILES | O=C1CCCC1 |
PUBCHEM IUPAC INCHIKEY | BGTOWKSIORTVQH-UHFFFAOYSA-N |
Solubility Level | 4 |
Vapour Pressure | 0.899 |
XLOGP3 AA | NA |
CACTVS TPSA | 20.23 |
BBB Level | 2 |
Absorption Level | 1 |
EXT PPB#Prediction | 0 |
AlogP98 | 0.858 |
EXT CYP2D6#Prediction | 0 |
Mouse Female FDA | Multi-Carcinogen |
Mouse Male FDA | Multi-Carcinogen |
Rat Female FDA | Single-Carcinogen |
Rat Male FDA | Multi-Carcinogen |
Ames Prediction | Non-Mutagen |
Developmental / Reproductive Toxicity | Non-Toxic |
Rat Oral LD50 | 1.27993 |
Ocular Irritancy | Mild |
Hepatotoxic#Prediction | 0 |
Effected Human Genes | NA |
Aerobic Biodegradability Prediction | Degradable |
Physical hazards | not classified |
Health hazards | Moderate |
Environmental hazards | not classified |
Serial No. | Cas No | Gene Symbol | Organism | Interaction | Interaction Actions | PubMed Id |
---|---|---|---|---|---|---|
1 | 120-92-3 | AKR1C2 | Homo sapiens | [AKR1C2 protein co-treated with NADP] results in increased reduction of cyclopentanone | affects^cotreatment|increases^reduction | 23261716 |
2 | 120-92-3 | AKR1C2 | Homo sapiens | Ursodeoxycholic Acid inhibits the reaction [[AKR1C2 protein co-treated with NADP] results in increased reduction of cyclopentanone] | affects^cotreatment|decreases^reaction|increases^reduction | 23261716 |
3 | 120-92-3 | AKR1C3 | Homo sapiens | [AKR1C3 protein co-treated with NADP] results in increased reduction of cyclopentanone | affects^cotreatment|increases^reduction | 23261716 |
4 | 120-92-3 | AKR1C3 | Homo sapiens | Medroxyprogesterone Acetate inhibits the reaction [[AKR1C3 protein co-treated with NADP] results in increased reduction of cyclopentanone] | affects^cotreatment|decreases^reaction|increases^reduction | 23261716 |
Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
---|---|---|---|---|---|
1 | 120-92-3 | Cyclopentanone |